Zydus Wellness Ltd Q2 FY2023 Concall Summary

Key Takeaways

• Volume resilient, margins squeezed: 5% volume growth in a subdued demand environment was a bright spot, but milk inflation and a surprise wage hike compressed gross and operating margins.
• Milk is the single largest margin villain: An unexpected spike in milk prices to INR 53 hurt dairy-heavy products, and price hikes to recover margin will lag due to inventory.
• Complan is losing ground in sachets: The HFD category is degrowing, and Complan’s market share is under pressure because it was late to the sachet and pouch trend that now drives 27% of the category.
• Distribution expansion is a bet, not a guarantee: Management is adding outlets aggressively but explicitly warns that outlet growth no longer correlates linearly with sales growth in general trade.
• What to watch next quarter: Whether the full Complan sachet rollout by Q3 recovers market share, the pace of gross margin recovery as price hikes flow through, and any sign of the hoped-for rural demand revival.

Demand & Volume: A Tale of Two Consumers

• Urban affluent held up, rural traded down: Top-end direct distribution and organized trade performed better, while the sub-stockist channel serving lower population strata was muted, confirming broad-based stress at the mass end.
• Rural demand subdued: Rural markets, which contribute 25% of net sales, saw slower pickup than urban, with visible down-trading.
• HFD category in structural decline: The health food drinks category has been degrowing for three consecutive quarters per Nielsen, and Complan reflected that trend.
• Green shoots in modern trade and e-commerce: Complan’s market share is improving in these channels even as overall category demand remains weak.
• Bet on rural revival: Management is hopeful that a good monsoon and government spending will revive rural demand, but this remains an expectation rather than a confirmed trend.

Complan: The Sachet Gap and Market Share Fight

• Late to the sachet party: Sachets grew from 12-15% to 27% of the HFD category, but Zydus was behind the curve in driving this format, which directly hurt Complan’s market share.
• Pouch packs added competitive pressure: Competitors introduced pouch packs that further eroded Complan’s position in the value segment.
• Recovery playbook is in motion: Sachet rollout began 5-6 months ago and is not yet complete across all markets; full rollout is expected by Q3.
• Early signs of share recovery: In the last 4 months, market share has started recovering, though this will only become visible in MAT data with a lag.
• Large-pack kid segment intact: Where Complan competes in larger packs for kids, market shares are reasonably stable; the damage is concentrated in the lower-price-point formats.
• Pricing handcuffed by competition: Complan is the only brand where Zydus is not the category leader, so it must be more guarded on pricing, limiting its ability to pass through input costs.

Tarun Arora: "the proliferation of sachets becoming 26%, 27% of the category really makes it a much wider reach. And given the pricing of this category being reasonably high and inflationary times, I think they've just been a space that we see is proliferating across the board."

Margins: Milk, Wages, and the Path Back

• Gross margin hit from two sides: Milk prices were the single largest drag, compounded by an adverse mix shift as lower-margin dairy byproducts and parts of the Nutralite portfolio grew faster.
• Wage shock in the Northeast: A statutory wage rate revision in the Northeastern belt, where some manufacturing facilities are located, came with very little notice and pushed other expenses up 15.1%.
• Price hikes are flowing, but with a lag: A 2%-plus price increase has been implemented across the portfolio, but the inventory cycle of converting milk into SMP delays the margin benefit.
• No margin protection at the cost of growth: Management explicitly chose not to cut customer promotions or credit promotions aggressively, prioritizing volume and market presence over short-term margin defense.
• Q4 is the margin normalization target: Management expects to fully catch up on margins by Q4, managing the recovery month-on-month.

Sharvil Patel: "This volatility of sharp increase was not ever expected. So that has obviously taken all of us by surprise that we would signal going all the way to INR 53."

Portfolio: What Grew, What Stalled

• Glucon-D leveraged a second summer: Strong double-digit sales growth, driven by media activations and a TV campaign that capitalized on an extended warm season.
• Everyuth sustained momentum: Another quarter of strong double-digit growth, supported by TV and digital campaigns and a prolonged monsoon that boosted scrubs, peel-offs and face wash.
• Nycil delivered double-digit growth: Supported by TV campaigns, the brand maintained its trajectory.
• Sugar Free stalled on a high base: Flattish growth in Q2, consistent with a historical yo-yo pattern where good years are followed by flat ones; long-term trend is high single-digit growth.
• Nutralite performed well across the portfolio: Both the dairy side and the traditional core showed good progress, and management sees it becoming a top-5 brand for the company.

Distribution & Innovation: Building for the Long Term

• One lakh outlet expansion underway: Half a lakh new outlets have already been added in recent months, with the full target of one lakh for this financial year in progress.
• Three-year ambition of one million outlets: The company plans to grow from 600,000 to one million outlets, with a steady plan and a new innovation or model in the works.
• Outlet growth is not sales growth: Management is explicit that the historical linear correlation between outlets and sales has broken down across FMCG, and general trade sales growth has lagged outlet expansion.
• Innovation pipeline is incremental, not transformational: Current bets are on already-launched products like DoodhShakti butter, Sugarlite, and a body lotion; new products have a 2-3 year gestation and will not carry the growth thesis.

Tarun Arora: "New products, I can't say, there are one or two which have a good potential, but I will not carry my growth dependence on them. If they grow faster, sure. But largely, our growth thesis is based on what we already have in the market."

Profit Seasonality: A Structural Quirk

• Q4 and Q1 deliver 83-84% of profits: The last two quarters are very small in absolute profit terms, so even modest INR 3-5 crore swings create large percentage movements.
• Management wants to smooth this out: Over time, the company aims to improve profit stability in the smaller quarters, though no specific timeline was given.

Sharvil Patel: "The fourth and first quarter are where close to 83%, 84% of our profits are, and the last two quarters are very small. So while we have had a very big headwind in terms of price increases. But in terms of the overall company, these two quarters are the smallest quarters when it comes to our profit..."

Guidance & Commitments

Key Metrics